This presentation emphasizes the critical role of GDP (Good Distribution Practice) logistics within the pharmaceutical value chain. It is designed for professionals and decision-makers in the pharmaceutical industry, logistics service providers, and those responsible for quality assurance and regulatory compliance. The goal is to provide participants with practical insights into maintaining regulatory compliance and product integrity throughout the entire distribution process.
The session offers a detailed overview of the GDP logistics workflow—from planning and documentation through shipment preparation, transport execution, arrival and unloading, to final reporting. Real-world case studies, such as the validation of transport boxes under varying conditions and temperature monitoring, illustrate how theoretical requirements translate into practical solutions.
Another key focus is documentation and certification. Participants will learn what constitutes complete documentation, how GDP certification (e.g., by Dekra) is achieved, and how customer-specific SOPs can be integrated flexibly. The advantages of working with certified logistics partners are highlighted alongside proven best practices, including careful personnel selection and training, the use of temperature-controlled transport, real-time monitoring, crisis management, and continuous process improvement.
Attendees will gain actionable knowledge on implementing regulatory requirements in daily operations, ensuring product quality and safety through targeted measures, and achieving full traceability and compliance via professional documentation and validation. They will also explore common challenges and practical solutions for meeting GDP standards and discover strategies for long-term optimization through audits and continuous improvement processes.
This presentation is particularly relevant for professionals and managers in logistics, quality assurance, and supply chain management, as well as those responsible for audits and regulatory matters in the pharmaceutical sector. Logistics service providers engaged in GDP-related activities will also benefit greatly.
While a basic understanding of pharmaceutical logistics and regulatory frameworks—especially GDP—is helpful, it is not essential. The content is structured to ensure that even participants with limited prior experience gain a comprehensive, practice-oriented overview.
Ultimately, this presentation delivers a well-founded and practical guide to GDP logistics, clarifies regulatory requirements and their implementation, and provides concrete recommendations for the safe, compliant, and quality-assured distribution of medicinal products.
